US Patent Issued to Novartis on Jan. 13 for "Computerized systems for prediction of geographic atrophy progression using deep learning applied to clinical imaging" (French, Swiss Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,525,335, issued on Jan. 13, was assigned to Novartis AG (Basel, Switzerland).

"Computerized systems for prediction of geographic atrophy progression using deep learning applied to clinical imaging" was invented by Guillaume Meyers-Normand (Basel, Switzerland), Ronan Danno (Saint Contest, France), Bruno Lay (Saint Contest, France), Gwenole Quellec (Brest, France) and Georges Weissgerber (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "An electronic device is disclosed. The device receives retinal images and patient data corresponding to the retinal images. The device can train a first machine learning model ("model") based on a first gr...